Detrimental effect of fractalkine on myocardial ischaemia and heart failure

Cardiovascular Research

Volumn 92, Issue 3, 2011, Pages 385-393

  Xuan, Wanling ^a,b   Liao, Yulin ^a   Chen, Baihe ^a,b   Huang, Qiaobing ^b   Xu, Dingli ^a   Liu, Yili ^a   Bin, Jianping ^a   Kitakaze, Masafumi ^a,c  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Fractalkine; Heart failure; Mitogen activated protein kinases; Myocardial ischaemia

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA; BRAIN NATRIURETIC PEPTIDE; FRACTALKINE; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ARTICLE; BODY WEIGHT; CELL DAMAGE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; FIBROBLAST; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; LUNG WEIGHT; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, NEUTRALIZING; ATRIAL NATRIURETIC FACTOR; CELLS, CULTURED; CHEMOKINE CX3CL1; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FIBROBLASTS; HEART FAILURE; INTERCELLULAR ADHESION MOLECULE-1; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; RATS; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VENTRICULAR REMODELING;

EID: 81055133113     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr221     Document Type: Article

References (32)

1. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997;385:640-644.
2. Saederup N, Chan L, Lira SA, Charo IF. Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/-mice: evidence for independent chemokine functions in atherogenesis. Circulation 2008;117: 1642-1648. (Pubitemid 351482604)
3. Cockwell P, Chakravorty SJ, Girdlestone J, Savage CO. Fractalkine expression in human renal inflammation. J Pathol 2002;196:85-90.
4. Tarozzo G, Campanella M, Ghiani M, Bulfone A, Beltramo M. Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat. Eur J Neurosci 2002;15:1663-1668. (Pubitemid 35471922)
5. Damas JK, Boullier A, Waehre T, Smith C, Sandberg WJ, Green S et al. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy. Arterioscler Thromb Vasc Biol 2005;25: 2567-2572. (Pubitemid 43732280)
6. Yang XP, Mattagajasingh S, Su S, Chen G, Cai Z, Fox-Talbot K et al. Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway. Circ Res 2007;101:1001-1008. (Pubitemid 350084977)
7. Furuichi K, Gao JL, Murphy PM. Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. Am J Pathol 2006;169:372-387. (Pubitemid 44156300)
8. Soriano SG, Amaravadi LS, Wang YF, Zhou H, Yu GX, Tonra JR et al. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol 2002;125:59-65. (Pubitemid 34327454)
9. McDermott DH, Fong AM, Yang Q, Sechler JM, Cupples LA, Merrell MN et al. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 2003;111: 1241-1250. (Pubitemid 36519941)
10. Husberg C, Nygard S, Finsen AV, Damas JK, Frigessi A, Oie E et al. Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. J Mol Cell Cardiol 2008;45:261-269.
11. Klosowska K, Volin MV, Huynh N, Chong KK, Halloran MM, Woods JM. Fractalkine functions as a chemoattractant for osteoarthritis synovial fibroblasts and stimulates phosphorylation of mitogen-activated protein kinases and Akt. Clin Exp Immunol 2009;156:312-319.
12. Volin MV, Huynh N, Klosowska K, Reyes RD, Woods JM. Fractalkine-induced endothelial cell migration requires MAP kinase signaling. Pathobiology 2010;77:7-16.
13. Petrich BG, Wang Y. Stress-activated MAP kinases in cardiac remodeling and heart failure; new insights from transgenic studies. Trends Cardiovasc Med 2004;14:50-55. (Pubitemid 38340846)
14. Ravingerova T, Barancik M, Strniskova M. Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology. Mol Cell Biochem 2003;247:127-138. (Pubitemid 36798517)
15. Liao Y, Takashima S, Zhao H, Asano Y, Shintani Y, Minamino T et al. Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice. Cardiovasc Res 2006;70:107-116.
16. Krishnamurthy P, Subramanian V, Singh M, Singh K. Deficiency of beta1 integrins results in increased myocardial dysfunction after myocardial infarction. Heart 2006; 92:1309-1315. (Pubitemid 44298891)
17. Korhonen T, Hanninen SL, Tavi P. Model of excitation-contraction coupling of rat neonatal ventricular myocytes. Biophys J 2009;96:1189-1209.
18. Tiede K, Melchior-Becker A, Fischer JW. Transcriptional and posttranscriptional regulators of biglycan in cardiac fibroblasts. Basic Res Cardiol 2010;105:99-108.
19. Mountain DJ, Singh M, Menon B, Singh K. Interleukin-1beta increases expression and activity of matrix metalloproteinase-2 in cardiac microvascular endothelial cells: role of PKCalpha/beta1 and MAPKs. Am J Physiol Cell Physiol 2007;292:C867-C875.
20. Koyama T, Temma K, Akera T. Reperfusion-induced contracture develops with a decreasing [Ca2+]i in single heart cells. Am J Physiol 1991;261:H1115-H1122.
21. Liao Y, Xuan W, Zhao J, Bin J, Zhao H, Asakura M et al. Antihypertrophic effects of adiponectin on cardiomyocytes are associated with the inhibition of heparin-binding epidermal growth factor signaling. Biochem Biophys Res Commun 2010;393:519-525.
22. Jiang DQ, Liu H, Zhang SB, Zhang XL. Aspirin inhibits tumor necrosis factor-alpha-stimulated fractalkine expression in human umbilical vein endothelial cells. Chin Med J (Engl) 2009;122:1147-1153.
23. White GE, Tan TC, John AE, Whatling C, McPheat WL, Greaves DR. Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling. Cardiovasc Res 2010;85:825-835.
24. Kikuchi Y, Imakiire T, Hyodo T, Kushiyama T, Higashi K, Hyodo N et al. Advanced glycation end-product induces fractalkine gene upregulation in normal rat glomeruli. Nephrol Dial Transplant 2005;20:2690-2696. (Pubitemid 41672267)
25. Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep 2009;61: 22-32.
26. Schafer A, Schulz C, Fraccarollo D, Tas P, Leutke M, Eigenthaler M et al. The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions. Arterioscler Thromb Vasc Biol 2007;27:55-62. (Pubitemid 46360381)
27. Koziolek MJ, Muller GA, Zapf A, Patschan D, Schmid H, Cohen CD et al. Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure. Nephrol Dial Transplant 2010;25:684-698.
28. Schulz C, Schafer A, Stolla M, Kerstan S, Lorenz M, von Bruhl ML et al. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation 2007;116:764-773. (Pubitemid 47255994)
29. Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie O, Imai T et al. Fractalkine and CX3CR1 mediate a novel mechanism of leucocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 1998;188:1413-1419. (Pubitemid 28489578)
30. Nabah YN, Mateo T, Estelles R, Mata M, Zagorski J, Sarau H et al. Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines. Circulation 2004;110:3581-3586. (Pubitemid 39612574)
31. Dong F, Khalil M, Kiedrowski M, O'Connor C, Petrovic E, Zhou X et al. Critical role for leukocyte hypoxia inducible factor-1alpha expression in post-myocardial infarction left ventricular remodeling. Circ Res 2010;106:601-610.
32. Imaizumi T, Yoshida H, Satoh K. Regulation of CX3CL1/fractalkine expression in endothelial cells. J Atheroscler Thromb 2004;11:15-21.